"The Genesis Cancer Care Institute helps patients beat cancer by using the next generation of cancer-fighting technology, combined with a focus on resources and support for the patient and family."

During the past decade, Genesis Cancer Care Institute conducted 31 clinical trials. In the 10-year time frame, 31 clinical trials started and 14 clinical trials were completed, i.e. on average, 45.2% percent of trials that started reached the finish line to date. In the past 5 years, 14 clinical trials started and 6 clinical trials were completed. i.e. 42.9% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Genesis Cancer Care Institute" #1 sponsor was "National Cancer Institute (NCI)" with 22 trials, followed by "Alliance for Clinical Trials in Oncology" with 7 trials sponsored, "SWOG Cancer Research Network" with 7 trials sponsored, "ECOG-ACRIN Cancer Research Group" with 3 trials sponsored and "NRG Oncology" with 3 trials sponsored. Other sponsors include -4 different institutions and companies that sponsored additional 6 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Genesis Cancer Care Institute" #1 collaborator was "National Cancer Institute (NCI)" with 20 trials as a collaborator, "Cancer and Leukemia Group B" with 4 trials as a collaborator, "SWOG Cancer Research Network" with 4 trials as a collaborator, "NCIC Clinical Trials Group" with 3 trials as a collaborator and "North Central Cancer Treatment Group" with 3 trials as a collaborator. Other collaborators include 6 different institutions and companies that were collaborators in the rest 15 trials.

According to Clinical.Site data, the most researched conditions in "Genesis Cancer Care Institute" are "Invasive Breast Carcinoma" (5 trials), "Stage IV Lung Cancer AJCC v8" (5 trials), "Stage IVA Lung Cancer AJCC v8" (5 trials), "Stage IVB Lung Cancer AJCC v8" (5 trials) and "Estrogen Receptor Negative" (4 trials). Many other conditions were trialed in "Genesis Cancer Care Institute" in a lesser frequency.

Most popular intervention types in "Genesis Cancer Care Institute" are "Drug" (34 trials), "Other" (28 trials), "Biological" (18 trials), "Procedure" (10 trials) and "Radiation" (4 trials). Other intervention types were less common.

The name of intervention was led by "Laboratory Biomarker Analysis" (15 trials), "Quality-of-Life Assessment" (13 trials), "Biospecimen Collection" (8 trials), "Cisplatin" (8 trials) and "Paclitaxel" (8 trials). Other intervention names were less common.

The vast majority of trials in "Genesis Cancer Care Institute" are 36 trials for "All" genders and 6 trials for "Female" genders.

Currently, there are NaN active trials in "Genesis Cancer Care Institute". undefined are not yet recruiting, 12 are recruiting, 22 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 5 completed trials in Genesis Cancer Care Institute, 1 suspended trials, and 2 terminated clinical trials to date.

Out of the total trials that were conducted in Genesis Cancer Care Institute, 0 "Phase 1" clinical trials were conducted, 13 "Phase 2" clinical trials and 28 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 1 trials that are defined as “Not Applicable".